Navigation Links
Wiley signs collaboration agreement with the Asian Federation of Biotechnology
Date:9/18/2012

Weinheim, Germany. September 18, 2012. John Wiley & Sons, Inc., has announced the signing of a new collaboration agreement between Biotechnology Journal and the Asian Federation of Biotechnology (AFOB). From 2013 the Federation will contribute two special issues to the journal annually, while representatives from the AFOB will join the editorial board.

Since launching in 2006 Biotechnology Journal has become a truly international title. Edited by Professor Sang Yup Lee, from KAIST University in South Korea, and Professor Alois Jungbauer from BOKU University in Austria, the journal attracts international authors, a global readership and will be awarded an official Impact Factor in 2013.

As a partner journal of the AFOB, the Biotechnology Journal will work with the Federation to disseminate scientific knowledge from Asian research communities to a global audience by dedicating special issues to research and breakthroughs on topics that are relevant to all biotechnologists.

A new "AFOB Highlights" section will also be introduced to the journal as a forum for reporting Federation news, announcements, prizes and awards.

The AFOB will also contribute news and views to Wiley's BiotecVisions e-magazine, which will be circulated to all Federation members on a monthly basis.

Biotechnology Journal will continue to collaborate with the European Federation of Biotechnology section on Biochemical Engineering, placing it in a unique position to serve as a bridge between European and Asian biotechnologists.

"Wiley's mission is to bring the best of science to an international audience," said Carol Bacchus, Vice President and Publishing Director, Life Sciences, Wiley. "This AFOB collaboration is a new milestone, which will foster greater international co-operation between Asian and non-Asian scientists to enhance our knowledge in all areas and applications of biotechnology and engineering technolo
'/>"/>

Contact: Ben Norman
Sciencenewsroom@wiley.com
44-012-437-70375
Wiley
Source:Eurekalert

Page: 1 2

Related biology news :

1. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
2. Wiley-Blackwell launches new open-access journal: Food Science & Nutrition
3. Wiley launches new interdisciplinary review WIREs Energy and Environment
4. Report presents designs for study of cancer risks near US nuclear facilities
5. Buttercups alert farmers to first signs of subarctic fungus in the UK
6. Children exposed to the common pollutant naphthalene show signs of chromosomal damage
7. Brain scans detect early signs of autism
8. Novo Nordisk and BGI establish global collaboration framework
9. Copernicus Award 2012 for German-Polish collaboration in business information systems
10. Scripps Research Institute announces five-year research collaboration with Bristol-Myers Squibb
11. Grant program to spur new research on Alzheimers disease by encouraging collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/13/2015)...  higi, a leading cloud-based consumer engagement platform that ... with their communities around health and wellness, announced today ... API.  ... and convenient vehicle to receive validated health information from ... The API will allow higi,s trusted partners, on a ...
(Date:4/2/2015)... 2015 In the current ... outperforms the strongest competitors, showing outstanding performance in ... system is capable of a throughput of 5.000.000 ... to be ten times faster than most competitors ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... scientific conditions and measures, Johns Hopkins researchers have ... can induce mystical/spiritual experiences descriptively identical to spontaneous ... The resulting experiences apparently prompt positive changes in ... least. , The agent, a plant alkaloid ...
... on Long Island have identified which among several different kinds ... the widely prescribed antidepressant Prozac. This discovery might enable a ... side effects, to be developed. , The findings also lay ... how, when, and where new neurons are generated from stem ...
... for the first time that embryonic stem (ES) cells ... capacity to produce viable offspring. The research, published in ... avenues for future studies, including investigation of mechanisms involved ... for infertility. , Previous studies have shown that ES ...
Cached Biology News:Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience 2Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience 3Hopkins scientists show hallucinogen in mushrooms creates universal 'mystical' experience 4Prozac's target revealed 2Sperm created in the laboratory from embryonic stem cells produce viable progeny 2
(Date:4/24/2015)... 24, 2015 Leading Regenerative Veterinary ... its allogeneic stem-cell product development program and changes ... the corporate strategic direction. , “I am extremely ... stem cell development program has been kicked into ... manufacturing facility and hiring of our new Director ...
(Date:4/24/2015)... PRINCETON, N.J. , April 24, 2015  Navitas Life ... Kumar as Head of Clinical and Regulatory Services. Shalabh ... having been a co-founder and CEO of Kinapse, as well ... Logo - http://photos.prnewswire.com/prnh/20150423/201261LOGO ... Jim Tizzard commented "I am delighted to welcome ...
(Date:4/23/2015)... Dora, Florida (PRWEB) April 23, 2015 ... that it intends to conduct a groundbreaking pilot ... begin to be reversed in as little as ... the science of metabolic and nutritional medicine—will aggressively ... that cripple and destroy our aging brain. These ...
(Date:4/23/2015)... 2015 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology and medical device ... and the United States , today ... first quarter of 2015 after the New York Stock ... be Thursday morning, May 14, 2015 Shanghai time). The ...
Breaking Biology Technology:Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma 2Shalabh Kumar Joins Navitas Life Sciences to Lead their Clinical and Regulatory Services Teams 2New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 2WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 3
... by Novartis to evaluate safety and efficacy of Albuferon ... patients with genotypes 2 and 3 hepatitis C -ROCKVILLE, ... HGSI ) today announced that Novartis has ... evaluate the safety and efficacy of Albuferon(R) (albinterferon alfa-2b) ...
... 12 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... branded generic,pharmaceuticals and manufacturer of the patented anti-cancer ... today announced preliminary revenue,and earnings for the full ... Based upon preliminary data for the fourth quarter, ...
... Pharmaceuticals, a pioneer in the development of novel products ... disease, announced that Ted Hibben has joined the company ... from Coley Pharmaceutical Group, where he was most recently ... played a key role in the company,s $233 million ...
Cached Biology Technology:Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 2Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 3Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 4Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 5Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings 2Cequent Names Ted Hibben Chief Business Officer 2Cequent Names Ted Hibben Chief Business Officer 3
Yersinia pestis...
... The features we add to WinList come ... product every day. Features like automatic region ... the result of good suggestions, thoughtful conversations, ... the features you depend on are still ...
Insect Cell Lysis Buffer 50 ml...
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Biology Products: